Fresh analysis suggests that people who come off popular GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who end traditional diet and exercise regimens.
Findings released in a major medical journal demonstrates that while overweight people can lose a large proportion of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using these treatments should be cognizant of the potential of quick rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.
That rate of regain suggests a return to original mass in about 18 months.
Comparing Therapies
The study, which examined dozens of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Scientists point out that individuals who shed pounds through lifestyle changes alone typically experience a slower weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Quick Rebound
Experts propose the mode of action of the injections is key to understanding the heightened regain.
These medications copy a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of the hormone levels far above than the body's typical production may cause the system to produce less of its endogenous hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this medication means hunger is uncontrolled, making overeating a significant risk."
A Chronic Disease?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, due to the high risk of relapse, the therapy should be considered ongoing.
This view is echoed by pharmaceutical companies, who note that the results "emphasize the persistent nature of obesity," similar to managing conditions like diabetes.
User Experiences
Individuals who have come off the medication describe a powerful return of cravings.
"It was like a switch flipping and I was suddenly extremely hungry," said one woman.
This challenge is exacerbated if individuals have not established sustainable lifestyle or habit changes during therapy.
Growing Adoption
Survey data show that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is greater among females compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while the jabs are potent tools for weight loss, they are not a permanent fix and maintained weight loss likely depends on integrated behavioural support.